Top Markets
Coin of the day
Predictive Technology Group, Inc. Predictive Technology Group, Inc.

Predictive Technology Group, Inc.

PRED
주식 순위 #41304
Predictive Technology Group, Inc. (PRED), along with its affiliated companies,... Predictive Technology Group, Inc. (PRED), along with its affiliated companies, specializes in the creation and market introduction of cutting-edge molecular diagnostic and therapeutic solutions, as well as human cellular and tissue-based products (HCT/Ps). The company's operations are divided into two primary segments: Human Cellular and Tissue Products (HCT/Ps), and Diagnostics and Therapeutics. PRED offers genetic testing services like FertilityDX, which assists couples experiencing infertility, and ARTguide, a genetic test for women struggling with infertility often linked to endometriosis and other genetic conditions. In the realm of regenerative medicine, its product offerings include AmnioCyte, AmnioCyte Plus, PolyCyte, and CoreCyte. Furthermore, Predictive Technology Group has a cooperative arrangement with Atrin Pharmaceuticals LLC to advance molecular diagnostic tools, which are intended to refine the selection of patients for cancer treatments. Founded in 2005, the company initially operated under the name Global Enterprises Group, Inc., before rebranding to Predictive Technology Group, Inc. in July 2015. Its corporate headquarters are situated in Salt Lake City, Utah.
주가
$0.0001
마지막 동기화: 2024-12-31
시가총액
$28.10K
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Predictive Technology Group, Inc. (PRED)

카테고리

Predictive Technology Group, Inc. (PRED)의 수익
2026 기준 수익 TTM: 0
Predictive Technology Group, Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 수익 0과 동일입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
Predictive Technology Group, Inc.의 수익 기록 (2026 ~ 2026)
연말 수익
연도 수익 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 수익
회사 수익 수익 차이 국가
$5.27B -
US
$1.95B -
NL
- -
CH
- -
KR
$3.01B -
BE